Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Status: Unknown status Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20082
20111
20123
20142
20151
20183
20191
20212
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVAX Technologies1
Arno Therapeutics1
Aronex Pharmaceuticals1
Asan Medical Center1
Catholic University of the Sacred Heart1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Herbert Irving Comprehensive Cancer Center1
ImmVira Pharma Co. Ltd1
Immix Biopharma Australia Pty Ltd1
Innolake Biopharm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms23
Breast Neoplasms6
Colorectal Neoplasms5
Melanoma5
Pancreatic Neoplasms5
Carcinoma, Hepatocellular4
Carcinoma, Ovarian Epithelial4
Endometrial Neoplasms4
Esophageal Neoplasms3
Lung Neoplasms3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.